Skip to content
  • Sunday, 26 July 2026
  • 1:40 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Sample ages bolster a rising tide doubting a singular 3.9 billion-year-old lunar cataclysm
Environmental & Analytical Chemistry

Sample ages bolster a rising tide doubting a singular 3.9 billion-year-old lunar cataclysm

Abdurrohim Arsyad Jul 23, 2026 0

The long-held theory of a singular, cataclysmic bombardment of the inner solar system, often referred to as the Late Heavy…

Read More
Environmental & Analytical Chemistry

The Oddity of Ages: A Family Navigates a Unique Chronological Confluence

Abdurrohim Arsyad Jul 18, 2026 0

In the spring of 2025, the Fang-Mackey family began to observe a peculiar and statistically improbable phenomenon: all four members…

Read More
Top 10 Python Libraries for Data Engineering in 2026TWiV 1284: Clinical update with Dr. Daniel GriffinMicroplastics and Neurodegeneration: New Research Links Synthetic Particles to Alzheimer’s and Parkinson’s Disease RisksNovartis and Antares Therapeutics Forge Landmark Oncology Collaboration to Tackle Undruggable Cancer Targets
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ